BioSpace News Archive

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of a $56 million Series A financing.

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that the European Commission has granted a conditional marketing authorization for COVID-19 Vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union.

When 17-year-old Justin Bergen was in 6th grade, he began experiencing pain in his neck and his spine appeared to be growing at a slight angle.

TRIGR Therapeutics, Inc. (“TRIGR”), a clinical stage biopharmaceutical company focused on the development of multi-targeted angiogenic and immunomodulatory bispecific antibodies for oncology and certain ischemic indications, announced today the publication of a manuscript in the International Journal of Molecular Sciences,

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today announced that Sue Washer, President & Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Virtual BioConnect Conference held January 11 – 14, 2021.

STA Pharmaceutical, a WuXi AppTec Company (WuXi STA), announces their partner Innocare has received approval by the National Medical Products Administration of China (NMPA) for Orelabrutinib.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the H.C. Wainwright BioConnect 2021 Virtual Conference taking place January 11-14, 2021. The presentation will be available for on-demand listening beginning January 11, 2021 at 6:00 AM Eastern Time. Interested parties may access the recorded webcast of thi

Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops , will provide a corporate overview and update at the 39 th Annual J.P. Morgan Healthcare Conference. The presentation will take place virtually on Wednesday, Jan. 13, 2021 at 10:00 a.m. EST ( 3:00 p.m. GMT ), followed by a question and answ

Inov a lon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will present at the 23 rd Annual Needham Growth Conference, which will be held virtually. The virtual presentation will take place at 11:30 a.m. (EST) on Wednesday, Januar

F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announces that members of the management team will be participating in the H.C. Wainwright BioConnect Conference,